References
- Choi TY, Lee MS, Ernst E. Moxibustion for the treatment of chemotherapy-induced leukopenia: a systematic review of randomized clinical trials. Support Care Cancer. 2015;23(6):1819–1826.
- Sung H, Ferlay J, Siegel R, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.
- Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
- Kishida Y, Kawahara M, Teramukai S, et al. Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03. Br J Cancer. 2009;101(9):1537–1542.
- Doshi BD, Pandya NM, Shah CA, Gupta AK, Makwana MV. Chemotherapy-induced Neutropenia in cancer patients with solid tumors in India. Der Pharmacia Lettre. 2012;4(2):584–590.
- Choi CW, Sung HJ, Park KH, et al. Early lymphopenia as a risk factor for chemotherapy‐induced febrile neutropenia. Am J Hematol. 2003;73(4):263–266.
- Fontanella C, Bolzonello S, Lederer B, Aprile G. Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia. Breast Care. 2014;9(4):239–245.
- Hashiguchi Y, Kasai M, Fukuda T, Ichimura T, Yasui T, Sumi T. Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anticancer Drugs. 2015;26(10):1054–1060.
- Schwartzberg LS, Lal LS, Balu S, et al. Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar. Clin Econom Outcomes Res. 2018;10:493–500.
- Badr M, Hassan T, Sakr H, et al. Chemotherapy-induced neutropenia among pediatric cancer patients in Egypt: risks and consequences. Mol Clin Oncol. 2016;5(3):300–306.
- Gurlinka S, Kini P, Aroor S, Mundkur S. Factors associated with adverse outcome in pediatric febrile neutropenia: results from a tertiary care hospital. Int J Ped. 2017;5(12):6447–6455.
- Oguz A, Karadeniz C, Ckitak EC, Cil V. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia? Ped Hematol Oncol. 2006;23(2):143–151.
- Salako O, Okunade KS, Adeniji AA, Fagbenro GT, Afolaranmi OJ. Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria. Ecancermedicalscience. 2021;15:1188. doi:10.3332/ecancer.2021.1188
- Lyman GH. Risks and consequences of chemotherapy-induced neutropenia. Clin Cornerstone. 2006;8:S12–8. doi:10.1016/s1098-3597(06)80054-2
- Crawford J, Dale DC, Lyman GH. Chemotherapy induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004;100(2):228–237.
- Onoue M, Terada T, Okuda M, Fujimoto K, Imamura M, Inui KI. Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer. Int J Clin Oncol. 2004;9(3):174–178.
- Ye X, Zhai Q, Wang ZY, Du Q, Zhu B, Yu B. Neutropenic complications in Chinese patients with breast cancer in a real-world setting. Int J Clin Exp Oncol. 2017;10(1):651–660.
- Wesam AR, Almutairi FG, Mohammed A, et al. Risk factors of chemotherapy-induced neutropenia associated with folfox, folfiri, and folfoxiri regimens used in patients with advanced and metastatic colorectal cancer. Int J Med Res Health Sc. 2019;8(11):129–136.
- Han Y, Yu Z, Wen S, Zhang B, Cao X, Wang X. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer. Breast Cancer Res Treat. 2012;131(2):483–490.
- Weycker D, Barron R, Kartashov A, Legg J, Lyman GH. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. J Oncol Pharm Pract. 2014;20(3):190–198.
- Philip ML, Saj N, Sebastian AM, Mateti UV, Shetty V. Assessment of chemotherapy-induced febrile neutropenia in cancer patients. Indian J Med Paed Oncol. 2019;40(02):249–256.